Valo Health is a biotechnology company that uses artificial intelligence and machine learning to develop new drugs and therapies. The company was founded in 2019 by David Berry and is headquartered in Cambridge, Massachusetts. Valo Health's platform, Opal, uses data from various sources to identify new drug targets and predict the efficacy of potential treatments. The company has partnerships with major pharmaceutical companies such as Novartis and has raised $300 million in funding to date.